Stockholders' Equity

12 Months Ended

Dec. 31, 2013

Equity [Abstract]

Stockholders' Equity

NOTE 10—STOCKHOLDERS’ EQUITY

On July 25, 2013, the Company issued 4.5 million shares of its common stock, at a price to the public of $18.00 per share through a registered public offering. The Company granted the underwriters an option to purchase up to an additional 675 thousand shares of the Company’s common stock to cover over-allotments, if any, which the underwriters could exercise within 30 days of the date of the final prospectus. The underwriters purchased the additional 675 thousand shares of common stock on August 16, 2013. The offering was made pursuant to the Company’s existing shelf registration statement previously filed with the Securities and Exchange Commission (“SEC”). The net proceeds received from the transaction were approximately $88,043. The funds received from the issuance of the shares will be used for general corporate purposes, including potential acquisitions, working capital and other capital expenditures.

On April 11, 2012, the Company issued 4.0 million shares of its common stock, at a price to the public of $13.00 per share through a registered public offering. The Company granted the underwriters an option to purchase up to an additional 600,000 shares of the Company’s common stock to cover over-allotments, if any, which the underwriters could exercise within 30 days of the date of the final prospectus. The underwriters purchased the additional 600,000 shares of common stock on April 11, 2012. The offering was made pursuant to the Company’s effective shelf registration statement previously filed with the SEC. The net proceeds from the transaction were approximately $56,300. The funds received from the issuance of the shares will be used for general corporate purposes, including working capital, repayment of debt, possible acquisitions and other capital expenditures.

In March 2004, the Board of Directors adopted the 2004 Incentive Stock Plan (the “2004 Incentive Stock Plan”). The Company’s Compensation and Nominating Committee (or similar committee) may grant stock options, stock grants, stock units, and stock appreciation rights under the 2004 Incentive Stock Plan to certain eligible employees and to outside directors. As of December 31, 2013, there were 1,173,664 shares available for future grants under the 2004 Incentive Stock Plan. The Company’s policy is to issue new shares upon exercise of options and the issuance of stock grants.

The determination of the fair value of stock option awards on the date of grant using option-pricing models is affected by the Company’s stock price, as well as assumptions regarding a number of other inputs. These variables include the Company’s expected stock price volatility over the expected term of the awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The Company uses historical data to estimate stock option exercise and forfeiture rates. The expected term represents the period over which the share-based awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company’s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the stock options. All stock option awards are amortized based on their graded vesting over the requisite service period of the awards.

The Company also issues restricted stock awards to certain key employees. Generally, the restricted stock vests over a one to three year period and compensation expense is recognized over the one to three year period equal to the grant date value of the shares awarded to the employee. In addition, the Company issues performance-based awards which are dependent on the achievement of EBITDA targets and vest over a three-year period. As of December 31, 2013, the Company had 361,149 shares of performance-based awards outstanding, of which 230,750 have been earned due to the achievement of EBITDA targets. Performance-based stock awards are recognized as compensation expense over the vesting period based on the fair value on the date of grant and the number of shares ultimately expected to vest.

The Company’s total stock-based compensation expense was $2,527, $2,166 and $2,012 in 2013, 2012 and 2011, respectively. Included in stock based compensation expense for the year ended December 31, 2012, is $115 related to the accelerated vesting of stock-based awards to the Company’s former Vice President-General Manager Theatre Operations. Included in stock-based compensation expense for the year ended December 31, 2011, is $222 related to the accelerated vesting of stock-based awards to our former Senior Vice President-General Counsel and Secretary (see Note 21—Severance Agreement). Stock-based compensation expense is included in general and administrative expenses in the consolidated statement of operations with the exception of the accelerated vested awards which are included in Severance Agreement Charges. As of December 31, 2013, the Company had approximately $4,116 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company’s plans. This cost is expected to be recognized as stock-based compensation expense over a weighted-average period of 1.7 years. This expected cost does not include the impact of any future stock-based compensation awards.

Options

The Company currently uses the Black-Scholes option pricing model to determine the fair value of its stock options. Such stock options vest equally over a three-year period, except for options granted to members of the Board of Directors that vest immediately upon issuance. The stock options expire 10 years after the grant date.

No options were granted during 2013 and 2012. The following table sets forth information about the weighted-average fair value of options granted, and the weighted-average assumptions for such options granted, during 2011:

	2011
Weighted average fair value of options on grant date	$	4.87
Expected life (years)		6.0
Risk-free interest rate		2.3	%
Expected dividend yield		—	%
Expected volatility		76.2	%

The Company’s stock-based compensation expense is recorded based on an estimated forfeiture rate of 5%.

The following table sets forth the summary of option activity for the year ended December 31, 2013:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at January 1, 2013		747,500		$	12.32		5.92
Granted		—		$	—		—	$	—
Exercised		(15,000	)	$	8.38				232
Expired		(125,000	)	$	29.52
Forfeited		—		$	—
Outstanding at December 31, 2013		607,500		$	8.88		6.04	$	11,567
Exercisable on December 31, 2013		556,662		$	9.03		5.93	$	10,520
Expected to vest at December 31, 2013		50,235		$	7.23		7.23	$	1,035

The fair value of options vested during the years ended December 31, 2013, 2012 and 2011 was $588, $1,239, and $1,213, respectively. The intrinsic value of the options exercised during the years ended December 31, 2013 and 2012 was $232 and $245, respectively. Cash received from options exercised for the years ended December 31, 2013 and 2012 was $126 and $305, respectively. The cash tax benefits realized from stock awards exercised for December 31, 2013 and 2012 were $88 and $93, respectively. No options were exercised in 2011.

Restricted Stock

The following table sets forth the summary of activity for restricted stock grants for the year ended December 31, 2013:

	2013					2012					2011
	Shares			Weighted Average Grant  Date Fair Value		Shares			Weighted Average Grant  Date Fair Value		Shares			Weighted Average Grant  Date Fair Value
Nonvested at beginning of year		458,981		$	10.85		248,804		$	8.43		131,333		$	10.58
Granted		215,800		$	15.77		288,648		$	12.18		165,638		$	7.22
Vested		(97,928	)	$	11.78		(72,471	)	$	7.81		(43,167	)	$	10.47
Forfeited		(3,500	)	$	15.66		(6,000	)	$	10.91		(5,000	)	$	7.34
Nonvested at end of year		573,353		$	12.51		458,981		$	10.85		248,804		$	8.43

The total fair value for restricted share awards that vested during 2013, 2012 and 2011 was $1,617, $990 and $296, respectively.